During the past decade, Nevada Headache Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nevada Headache Institute" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Allergan" with 1 trials sponsored, "Autonomic Technologies, Inc." with 1 trials sponsored, "H. Lundbeck A/S" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nevada Headache Institute" #1 collaborator was "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nevada Headache Institute" are "Migraine" (4 trials), "Chronic Cluster Headache" (1 trials), "Cluster Headache" (1 trials) and "Episodic Migraine" (1 trials). Many other conditions were trialed in "Nevada Headache Institute" in a lesser frequency.

Most popular intervention types in "Nevada Headache Institute" are "Drug" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "ATI Neurostimulation System" (1 trials), "Atogepant" (1 trials), "C213 Microneedle System" (1 trials) and "Eptinezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nevada Headache Institute" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Nevada Headache Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Nevada Headache Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nevada Headache Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".